223Ra

You have access
The Prognostic Value of Quantitative Bone SPECT/CT Before ²²³Ra Treatment in Metastatic Castration-Resistant Prostate Cancer
Helmut Dittmann, Sabine Kaltenbach, Matthias Weissinger, Francesco Fiz, Peter Martus, Maren Pritzkow, Juergen Kupferschlaeger and Christian la Fougère

Journal of Nuclear Medicine January 1, 2021, 62 (1) 48-54; DOI: https://doi.org/10.2967/jnumed.119.240408
You have access
Assessing Radiographic Response to ²²³Ra with an Automated Bone Scan Index in Metastatic Castration-Resistant Prostate Cancer Patients
Aseem Anand, Elin Trägårdh, Lars Edenbrandt, Lars Beckman, Jan-Henry Svensson, Camilla Thellenberg, Anders Widmark, Jon Kindblom, Anders Ullén and Anders Bjartell

Journal of Nuclear Medicine May 1, 2020, 61 (5) 671-675; DOI: https://doi.org/10.2967/jnumed.119.231100
You have access
Dose-Dependent Growth Delay of Breast Cancer Xenografts in the Bone Marrow of Mice Treated with ²²³Ra: The Role of Bystander Effects and Their Potential for Therapy
Calvin N. Leung, Brian S. Canter, Didier Rajon, Tom A. Bäck, J. Christopher Fritton, Edouard I. Azzam and Roger W. Howell

Journal of Nuclear Medicine January 1, 2020, 61 (1) 89-95; DOI: https://doi.org/10.2967/jnumed.119.227835
You have access
²²³Ra Therapy of Advanced Metastatic Castration-Resistant Prostate Cancer: Quantitative Assessment of Skeletal Tumor Burden for Prognostication of Clinical Outcome and Hematologic Toxicity
Marie Øbro Fosbøl, Peter Meidahl Petersen, Andreas Kjaer and Jann Mortensen

Journal of Nuclear Medicine April 1, 2018, 59 (4) 596-602; DOI: https://doi.org/10.2967/jnumed.117.195677
You have access
⁶⁸Ga-PSMA-11 PET as a Gatekeeper for the Treatment of Metastatic Prostate Cancer with ²²³Ra: Proof of Concept
Hojjat Ahmadzadehfar, Kambiz Azgomi, Stefan Hauser, Xiao Wei, Anna Yordanova, Florian C. Gaertner, Stefan Kürpig, Holger Strunk and Markus Essler

Journal of Nuclear Medicine March 1, 2017, 58 (3) 438-444; DOI: https://doi.org/10.2967/jnumed.116.178533
You have access
A Phase 1, Open-Label Study of the Biodistribution, Pharmacokinetics, and Dosimetry of ²²³Ra-Dichloride in Patients with Hormone-Refractory Prostate Cancer and Skeletal Metastases
Sarah J. Chittenden, Cecilia Hindorf, Christopher C. Parker, Valerie J. Lewington, Brenda E. Pratt, Bernadette Johnson and Glenn D. Flux

Journal of Nuclear Medicine September 1, 2015, 56 (9) 1304-1309; DOI: https://doi.org/10.2967/jnumed.115.157123
You have access
Prognostic Factors in Patients Treated with ²²³Ra: The Role of Skeletal Tumor Burden on Baseline ¹⁸F-Fluoride PET/CT in Predicting Overall Survival
Elba C. Etchebehere, John C. Araujo, Patricia S. Fox, Nancy M. Swanston, Homer A. Macapinlac and Eric M. Rohren

Journal of Nuclear Medicine August 1, 2015, 56 (8) 1177-1184; DOI: https://doi.org/10.2967/jnumed.115.158626

Main menu

User menu

Search

223Ra